First Time Loading...

Oramed Pharmaceuticals Inc
NASDAQ:ORMP

Watchlist Manager
Oramed Pharmaceuticals Inc Logo
Oramed Pharmaceuticals Inc
NASDAQ:ORMP
Watchlist
Price: 2.38 USD -2.06% Market Closed
Updated: May 10, 2024
Section:
 

Wall Street
Price Targets

ORMP Price Targets Summary
Oramed Pharmaceuticals Inc

Wall Street analysts forecast ORMP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ORMP is 4.34 USD with a low forecast of 4.29 USD and a high forecast of 4.46 USD.

ORMP Lowest Forecast
Wall Street Target
4.29 USD
80% Upside
ORMP Average Forecast
Wall Street Target
4.34 USD
82% Upside
ORMP Highest Forecast
Wall Street Target
4.46 USD
88% Upside
Lowest
Price Target
4.29 USD
80% Upside
Average
Price Target
4.34 USD
82% Upside
Highest
Price Target
4.46 USD
88% Upside
Oramed Pharmaceuticals Inc Competitors:
Price Targets
K
KILITCH
Kilitch Drugs (India) Ltd
45% Upside
600479
ZhuZhou QianJin Pharmaceutical Co Ltd
31% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
22% Upside
C
060590
CTC Bio Inc
211% Upside
K
KILITCH
Kilitch Drugs (India) Ltd
45% Upside
600479
ZhuZhou QianJin Pharmaceutical Co Ltd
31% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
22% Upside
C
060590
CTC Bio Inc
211% Upside
002773
Chengdu Kanghong Pharmaceutical Group Co Ltd
2% Upside
BSEM
Biostem Technologies Inc
143% Upside
ALIM
Alimera Sciences Inc
141% Upside
F
FAE
Faes Farma SA
13% Upside

Revenue
Forecast

Revenue Estimate
Oramed Pharmaceuticals Inc

For the last 1 year the compound annual growth rate for Oramed Pharmaceuticals Inc's revenue is -50%.

-50%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Oramed Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Oramed Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
ORMP intrinsic value, competitors valuation, and company profile.
DCF Valuation
ORMP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ORMP stock valuation using valuation multiples.
Wall Street Estimates
ORMP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ORMP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORMP's stock price target?
Price Target
4.34 USD

According to Wall Street analysts, the average 1-year price target for ORMP is 4.34 USD with a low forecast of 4.29 USD and a high forecast of 4.46 USD.

ALPHA SPREAD
Join more than 135,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.